Are Drug Abusers Being Taken Care of Even After They Finish the Treatment Program?

Question by Tommy: Are drug abusers being taken care of even after they finish the treatment program?
I’m just curious about how things are after life in rehab. See, my friend Jack is about to finish his ten-week treatment program for his addiction with cocaine. I’m really happy to hear the news from his parents that he’s doing just fine. I just want to know if the treatment programs are extended after he leaves the rehab. I mean, do they have programs or activities that help drug abusers to continue with the healing process? I just want my friend to recover from his addiction for good.

Best answer:

Answer by mandy
Yes, of course. Some treatment programs include aftercare services that helps the drug abuser to recover completely. Such programs may include discussion groups, career planning, self-progress therapies and overall guidance. The staff of rehabilitation facilities make sure that their patient will forever leave his dirty old habit. Don’t worry about your friend too much. Have faith that he will make it to full recovery.

What do you think? Answer below!

 

Lilly reports on late-stage diabetes drug studies

Filed under: drug treatment news

s potential once-weekly treatment for type 2 diabetes fared better than three other drugs in lowering blood sugar levels, according to initial results from some late-stage research. The Indianapolis drugmaker said Monday that two doses of its …
Read more on Businessweek

 

New use for Thalidomide raises questions about drug's effects

Filed under: drug treatment news

While the drug was banned in 1962, it is again being prescribed — this time for treatment for multiple myeloma and other blood cancers — which its victims, now entering old age, often destitute and in increasing pain, find difficult to accept. "In my …
Read more on The Republic

 

Asian Countries Easing Access To Cheap Drugs

Filed under: drug treatment news

In March 2012, India approved its first compulsory license enabling a local company to produce a generic version of an anti-cancer drug, which could reduce the price of treating kidney and liver cancer from US$ 5,200 a month (the price of the branded …
Read more on IDN InDepthNews | Analysis That Matters